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RESEARCH
Engineering Corynebacterium glutamicum 
to produce the biogasoline isopentenol 
from plant biomass hydrolysates
Yusuke Sasaki1,2,3,5†, Thomas Eng3,5†, Robin A. Herbert3,5, Jessica Trinh3,5, Yan Chen3,5, Alberto Rodriguez3,4, 
John Gladden3,4, Blake A. Simmons3,5 , Christopher J. Petzold3,5 and Aindrila Mukhopadhyay3,5,6* 
Abstract 
Background: Many microbes used for the rapid discovery and development of metabolic pathways have sensitivi-
ties to final products and process reagents. Isopentenol (3-methyl-3-buten-1-ol), a biogasoline candidate, has an 
established heterologous gene pathway but is toxic to several microbial hosts. Reagents used in the pretreatment of 
plant biomass, such as ionic liquids, also inhibit growth of many host strains. We explored the use of Corynebacterium 
glutamicum as an alternative host to address these constraints.
Results: We found C. glutamicum ATCC 13032 to be tolerant to both the final product, isopentenol, as well to three 
classes of ionic liquids. A heterologous mevalonate-based isopentenol pathway was engineered in C. glutamicum. 
Targeted proteomics for the heterologous pathway proteins indicated that the 3-hydroxy-3-methylglutaryl-coenzyme 
A reductase protein, HmgR, is a potential rate-limiting enzyme in this synthetic pathway. Isopentenol titers were 
improved from undetectable to 1.25 g/L by combining three approaches: media optimization; substitution of an 
NADH-dependent HmgR homolog from Silicibacter pomeroyi; and development of a C. glutamicum ∆poxB ∆ldhA host 
chassis.
Conclusions: We describe the successful expression of a heterologous mevalonate-based pathway in the Gram-
positive industrial microorganism, C. glutamicum, for the production of the biogasoline candidate, isopentenol. We 
identified critical genetic factors to harness the isopentenol pathway in C. glutamicum. Further media and cultivation 
optimization enabled isopentenol production from sorghum biomass hydrolysates.
Keywords: Corynebacterium glutamicum, Sorghum, Hydrolysate, Ionic liquid pretreatment, Isopentenol, Isoprenol, 
3-Methyl-3-buten-1-ol, HmgR
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Background
Microbial hosts used for the rapid discovery and devel-
opment of metabolic pathways can have drawbacks that 
limit their biotechnological applications beyond the 
laboratory scale. These disadvantages include inhibition 
from components of the growth media and toxicity from 
metabolic intermediates or final products [1]. Solutions 
to several industrially relevant parameters and host 
sensitivities have been described, especially in model 
microbes such as Escherichia coli or Saccharomyces cer-
evisiae [2, 3], and are increasingly considered important 
for scale-up in an industrial process. However, if genetic 
tractability does not limit the choice of host organism, 
it is reasonable that any microbe could be utilized as a 
host for the expression of a heterologous gene pathway. 
Rather than develop solutions for individual aspects of 
an industrially relevant process, we viewed the choice of 
a microbial host as a means to bypass product and pro-
cess reagent toxicities that would be encountered in the 
industrial process.
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Corynebacterium glutamicum is a biotechnologically 
relevant host that presents several ideal characteristics 
for scale-up, such as a rapid phenotypic adjustment in 
response to environmental changes (e.g., oxygen lev-
els and substrate availability), which are major causes of 
performance losses in industrial scale bioreactors [4, 5]. 
Of particular relevance for renewable biofuel produc-
tion is its capacity of simultaneously utilizing glucose and 
xylose, two major components of plant biomass hydro-
lysates [6, 7], as well as p-coumaric and ferulic acids as 
carbon sources [8, 9]. These factors have contributed to 
the development of C. glutamicum as a production host 
for many bioproducts [10–12]. As a broad category, 
terpene-based compounds represent a rich source of 
biofuels and product targets [13]. Production of ter-
pene compounds has been explored in C. glutamicum 
but reported titers currently range from 0.2 to 23 mg/L 
for terpenes such as pinene and β-carotene, respectively 
[14]. Isopentenol (3-methyl-3-buten-1-ol) is a prominent 
example of a terpene compound that is desirable as both 
biogasoline as well as a platform chemical and has been 
developed in other microbial systems (e.g., E. coli) [15], 
but not in C. glutamicum.
Growth inhibitory effects of residual pretreatment 
reagents, used to release metabolizable carbon sources 
from plant biomass, is another factor to be considered in 
the use of renewable carbon sources. Ionic liquids (ILs) 
represent one such class of pretreatment reagents [16, 
17] and have advantages over conventional pretreat-
ments such as favorable sugar solubilization rates, less 
degradation of monosaccharides, and compatibility with 
downstream enzymatic processing [18]. ILs derived from 
1-ethyl-3-methylimidazolium  ([C2C1im]+) are known to 
be toxic against several eukaryotes [19] and Gram-neg-
ative bacteria [20]. New classes of ILs, such as cholinium 
 ([Ch]+) derived ILs [21] and protic ILs (such as ethan-
olamine acetate [ETA][OAc] and diethanolamine acetate 
[DEOA][OAc]) are emerging as equally effective but less 
toxic reagents for this application [22]. In contrast to 
other microbial hosts [23, 24], the physiological response 
of C. glutamicum has not been explored in detail to any 
of these ILs that remain as residual components in the 
biomass hydrolysate.
In this study, we explore the tolerance of C. glutamicum 
ATCC 13032 as a microbial platform for the heterologous 
mevalonate-based production pathway of isopentenol 
(Fig. 1). We characterized the innate tolerance of C. glu-
tamicum to isopentenol, which is known to be toxic to 
other microbes [25], as well three classes of ILs. Using 
the proteomics, we identify a critical protein in the heter-
ologous mevalonate pathway for isopentenol production. 
Furthermore, engineering the host strain background 
achieved isopentenol production in minimal defined 
media and IL extracted plant biomass hydrolysates in 
titers of 1.25 g/L and 1.1 g/L, respectively. These results 
highlight the potential of C. glutamicum as a sustainable 
production chassis to produce terpene-based biofuels 
and bioproducts.
Results
C. glutamicum is tolerant to three classes of ILs 
and exogenous isopentenol
We examined three broad IL classes: 1-ethyl-3-methyl 
imidazolium  ([C2C1im]+) derived; cholinium  ([Ch]+) 
derived; and protic: ethanolamine acetate [ETA][OAc] 
and diethanolamine acetate [DEOA][OAc]) in different 
cation/anion configurations, for toxicity against C. glu-
tamicum. The specific growth rate of C. glutamicum in 
the absence of any IL was 0.28 doublings per hour. C. glu-
tamicum grown in the presence of exogenous  [C2C1im]
[OAc] or  [C2C1im][Cl] indicated that this organism was 
tolerant to ~ 250 mM  [C2C1im]+ (Fig. 2a). Its growth rate 
decreased fourfold and is a three to six fold increase in 
tolerance of  [C2C1im]+ compared to wild-type E. coli 
(Additional file  1A). Of the cholinium based ILs, both 
[Ch][Lys] and [Ch][OAc] decreased growth rate by two to 
fourfold at 50 mM or higher. [Ch][Lys] was inhibitory at 
250 mM, while [Ch][OAc] decreased growth rate but was 
not inhibitory at concentrations of 150  mM and above 
(Fig. 2b). [Ch][Cl] was nontoxic to C. glutamicum, and no 
growth defect was observed, even when supplemented to 
600 mM (Fig. 2b). In contrast, E. coli was highly sensitive 
to [Ch][Lys], as it was inviable when [Ch][Lys] was added 
to the growth media at 40 mM (Additional file 1B). Etha-
nolamine- and diethanolamine-based ILs did not show a 
dosage dependent inhibition on C. glutamicum growth 
(Fig.  2c), suggesting that at tested concentrations these 
two representative protic ILs have no deleterious impact 
on C. glutamicum growth. As the concentration of ILs 
is below 100  mM in many commonly used hydrolysate 
preparations [26, 27], these results indicated that wild-
type C. glutamicum was innately tolerant to most forms 
of the trace ILs remaining in extracted hydrolysates from 
biomass. No further optimization was required to grow 
C. glutamicum in the presence of additional ILs from 
these three classes.
To examine the tolerance of C. glutamicum to isopen-
tenol and compare it against that in E. coli (known to 
show toxicity to exogenous isopentenol at a concentra-
tion of 0.2% (w/v) [25], we monitored and counted for-
mation of colony forming units (CFUs) on agar plates. 
We confirmed that E. coli is inviable in the presence of 
0.2% (w/v) isopentenol (Fig. 2d). In contrast, C. glutami-
cum is unperturbed at this concentration of isopentenol, 
as we observe a similar number of CFUs, albeit smaller 
and slower growing (Fig. 2d, compare the growth of LB 
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Fig. 1 Global map of central metabolic pathways in C. glutamicum ATCC 13032 and the heterologous mevalonate-based pathway for isopentenol 
production. The mevalonate-based isopentenol biosynthesis pathway was described in [28]. Broken lines show intermediate pathways omitted in 
glycolysis and the tricarboxylic acid cycle. The disrupted pathways in this work are shown in grey and indicated with a red “X”. Relevant reactions are 
represented by the genes encoding their corresponding enzymes. Reactions involved in isopentenol biosynthesis are displayed with red arrows. 
Abbreviations: atoB, acetyl-CoA acetyltransferase; HMGS, hydroxymethylglutaryl-CoA synthase; HMGR, 3-hydroxy-3-methylglutaryl-CoA reductase; 
MK, mevalonate kinase; PMD, phosphomevalonate decarboxylase; MEP, methylerythritol-4-phosphate; MVA, mevalonate; G6P, glucose-6-phosphate; 
F6P, fructose-6-phosphate; DAH, dihydroxyacetone phosphate; G3P, glyceraldehyde-3-phosphate; PEP, phosphoenolpyruvic acid; HMG-CoA, 3-hydro
xy-3-methyl-glutaryl-coenzyme A; HS-CoA, coenzyme A; Pi, inorganic phosphate
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plate to LB plus 0.2% (w/v) isopentenol plate). Wild-type 
C. glutamicum does not consume exogenous isopen-
tenol in liquid cultures as detected by GC-FID after 24 
or 48  h (Additional file  1C), where the decrease in iso-
pentenol concentration was comparable to isopentenol 
evaporation in a side-by-side comparison (Additional 
file  1C). Isopentenol evaporation was dependent on the 
cultivation format and was more pronounced in a 24-well 
deep well plate format (Additional file 1D). These results 
indicated that C. glutamicum has a higher tolerance of 
exogenous isopentenol compared to E. coli and also that 
C. glutamicum does not consume this final product as 
a carbon source. Together, these results suggested that 
selecting C. glutamicum as the microbial chassis is justi-
fied due to its inherent tolerance for a suite of relevant 
biofuel-related molecules.
Media, carbon and nitrogen levels dramatically impact 
isopentenol titers in C. glutamicum
Next, we expressed a heterologous mevalonate-based 
isopentenol biosynthesis pathway [28] in C. glutami-
cum (Fig.  1). Acetyl-coA is converted to mevalonate-
phosphate by four enzymatic reactions, which in turn is 
decarboxylated to isopentenyl monophosphate (a pro-
miscuous activity from PMD). Isopentenyl monophos-
phate is then spontaneously dephosphorylated by an 
endogenous phosphatase to yield isopentenol (Fig. 1). To 
identify the cultivation conditions for optimal produc-
tion of isopentenol in C. glutamicum, we tested M9 and 
CGXII media, a C. glutamicum specific minimal media as 
well as LB (Lysogeny Broth), and conditions were deter-
mined based on previous studies for non-native metab-
olite production [29]. We detected robust isopentenol 
production in CGXII media, at ~ 250  mg/L after 24  h 
and ~ 380 mg/L after 48 h (Additional file 2A). However, 
no isopentenol was detected when the strain was grown 
in either M9 media or LB irrespective of the additional 
d-glucose supplementation from 1% (w/v) to 4% (w/v) 
(Additional file 2A, B). The d-glucose concentration was 
an apparent difference between the CGXII medium and 
the other media. These observations demonstrated that 
the starting d-glucose concentration alone is insufficient 
to induce isopentenol production in C. glutamicum and 
growth in M9 or LB inhibits the production of isopen-
tenol. This result is in contrast to E. coli, where produc-
tion of isopentenol (and terpenes in general) is typically 
robust under nutrient-rich conditions, but limited under 
minimal media conditions [13, 15].
To examine the role of initial d-glucose concentration 
for production in CGXII media, we supplemented the 
medium with a range of starting d-glucose concentra-
tions [0.25% to 10% (w/v)] and repeated the isopentenol 
production (Fig.  3a). No isopentenol was detectable in 
the strains grown with less than 2% of initial d-glucose 
(Fig.  3a). Above 4% of d-glucose, we detected close 
to ~ 450 mg/L of isopentenol titers after 48 h of induction 
(Fig.  3a). The isopentenol titers were comparable up to 
8% of d-glucose but dropped threefold down to 100 mg/L 
at 10% of d-glucose (Fig.  3a). Under conditions where 
isopentenol production was detected, C. glutamicum 
Fig. 2 Assessment of C. glutamicum Resistance to Three Classes of 
ILs and Exogenous Isopentenol. a–c Growth assay for assessment 
of C. glutamicum resistance to ILs: C. glutamicum was cultured in 
CGXII minimal medium containing 4% d-glucose and the type 
and concentration of IL as indicated. Strains were cultivated in a 
96 well microtiter plate. The growth rate in either control media 
or supplemented with exogenous IL as indicated (1/h) was 
calculated and plotted as a function of IL concentration. Data is 
the average of three independent biological replicates, and error 
bars indicate standard error. d Spot assay for assessment of C. 
glutamicum and E. coli resistance to isopentenol. Cells were serially 
diluted tenfold onto solid LB agar media with or without 0.2% (w/v) 
isopentenol as indicated and incubated at 30 °C. Error bars are 
not plotted when they are shorter than the symbol used on the 
graph. Photomicrographs were taken after plates were incubated for 
2 days
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strains first accumulated both lactate and acetate at the 
24 h timepoint, and continued to accumulate additional 
acetate at the 48 h timepoint (Fig. 3b, c). The measured 
d-glucose concentration using HPLC indicated that it 
was completely consumed after 24 h in the strains grown 
with less than 4% d-glucose, but partially remained 
when they were grown with 4% or higher initial d-glu-
cose concentration, even after 48 h (Additional file 3A). 
The isopentenol production strains also produced 1 g/L 
of succinate, which did not change appreciably over the 
range of initial d-glucose (Additional file 3B). While there 
were differences in  OD600 values among these strains cul-
tured in different initial d-glucose concentrations, there 
was no correlation between culture density with iso-
pentenol titer, as r2 = 0.00053 (Additional file 3C). These 
results confirm that the starting d-glucose concentration 
can impact batch-mode production of isopentenol using 
C. glutamicum. A twofold change in the initial d-glucose 
concentration can have a 30-fold impact on isopentenol 
titer.
Next, we examined if the initial nitrogen concentration 
also influenced isopentenol titer. The nitrogen concentra-
tion in CGXII media was varied (the ratio of ammonium 
sulfate and urea were kept the same) and the d-glucose 
concentration was held constant at the standard 4% 
d-glucose (222  mM). There was a decrease in isopente-
nol titer as we varied the initial nitrogen concentration 
in either direction from the standard of 151 mM ammo-
nium sulfate with 83.3 mM urea [30] (Additional file 3D). 
Historically, the carbon:nitrogen ratio (C:N ratio) is 
known to impact the detectable levels of metabolites in 
log phase cultures [31]. The C:N ratio in the published 
CGXII media is 2.8 (6 × 222 mM d-glucose/2 × 151 mM 
ammonium sulfate plus 2 × 83.3  mM urea). We com-
bined the data for isopentenol production when we 
varied either nitrogen or d-glucose and re-plotted iso-
pentenol production as a function of the C:N ratio (Addi-
tional file 3E). The optimal C:N ratio in CGXII media was 
between 2.8 and 4.3. The C:N ratio in M9 media is con-
siderably higher at 17.8 (6 × 55.5 mM d-glucose/18.7 mM 
ammonium chloride), as the nitrogen concentration is 
25-fold lower. This ratio may contribute to the differ-
ences in measured isopentenol production, since no pro-
duction in M9 media was observed (Additional file 2A). 
These results illustrated that in terms of the C:N ratio, 
the  observed isopentenol titer was limited to a defined 
concentration range in which strains could produce 
detectable isopentenol titers.
Blocking organic acid formation yields limited 
improvements to isopentenol titer
Acetate and lactate formation increased under the cul-
tivation conditions we used for isopentenol production 
Fig. 3 Analysis of Different d-Glucose Concentrations for Isopentenol 
Production in C. glutamicum. a Impact of different starting d-glucose 
concentrations on isopentenol production titer. C. glutamicum was 
cultivated for isopentenol production in CGXII medium amended 
with d-glucose concentration from 0.25% to 10% (w/v) (13.9 mM 
to 550 mM) in 24-well deep well plates. For clarity, both the mM 
and  % (w/v) d-glucose concentrations are indicated on the x axis. 
b, c Analysis of generated lactate (b) and acetate (c) titer during 
the isopentenol production at the 24 h and 48 h timepoints. Error 
bars are not plotted when they are shorter than the symbol used 
on the graph. For all experiments, data was generated from three 
independent biological replicates for each condition, and error bars 
indicate standard error
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(Fig. 3a–c). To test if isopentenol titer could be improved 
by blocking formation of these organic acids, we targeted 
the genes encoding pyruvate oxidase (poxB) or lactate 
dehydrogenase (ldhA) for deletion. We generated the sin-
gle mutant strains ∆poxB and ∆ldhA, as well as a double 
mutant strain ∆poxB ∆ldhA to redirect flux away from 
either or both acetate or lactate. Resulting strains were 
then transformed with the isopentenol production plas-
mid. The wild-type C. glutamicum produced ~ 225 mg/L 
at the  24  h timepoint, which was slightly lower than 
previous production runs with this strain but within 
the error range, likely due to batch to batch varia-
tion in media preparation (Fig.  4). The ∆poxB mutant 
did not significantly improve isopentenol titer (Fig.  4), 
even though accumulation of acetate was reduced from 
5 g/L down to ~ 35 mg/L. The ∆ldhA strain did not pro-
duce more than trace isopentenol (Fig.  4). The ∆poxB 
∆ldhA strain continued to show marked improvement 
over the wild-type strain at the 48 h timepoint, produc-
ing ~ 500  mg/L isopentenol in the ∆poxB ∆ldhA strain 
(Fig.  4). The rational gene deletions in C. glutamicum 
lowered accumulation of side-products, but improve-
ments to isopentenol titer were limited to at most a two-
fold increase.
Expression of the isopentenol pathway protein HmgR 
strongly correlates with isopentenol titer
To examine if isopentenol titers correlate with path-
way protein expression, we used selected reaction 
monitoring (SRM) based proteomics [32–34] to assess 
relative protein levels across these conditions. Samples 
were grown in LB, M9, or CGXII media and collected 
at 24 and 48  h timepoints for proteomic analysis and 
GC analysis. We observed a similar dependence on the 
initial d-glucose concentration in CGXII media and a 
failure to produce isopentenol in M9 or LB irrespective 
of cultivation format (Additional file 4A). Crude lysates 
were prepared for peptide analysis to quantify the five 
proteins constituting the isopentenol pathway.
The targeted protein analysis indicated the highest 
protein abundance in the optimal condition (CGXII 
with 3% d-glucose), whereas in LB, all proteins in the 
isopentenol production pathway were reduced in their 
abundance ranging from twofold (PMD) to tenfold 
(HmgR) lower (Fig.  5a and Additional file  4B). Path-
way proteins from C. glutamicum grown in M9 media 
were reduced even further, as protein enrichment was 
decreased from sevenfold (PMD) to 27-fold (HmgS) 
(Fig.  5a and Additional file  4B). This analysis suggests 
that the failure to produce isopentenol in either LB or 
M9 media was due to the decreased abundance of the 
isopentenol pathway proteins.
Proteomics data also revealed potential bottlenecks 
in the isopentenol production pathway. Across the 
range of cultivation parameters and timepoints tested 
in wild-type C. glutamicum, we observed that HmgR 
protein levels and its isopentenol production titer were 
strongly correlated  (r2 = 0.93) (Fig. 5b). The other four 
pathway proteins (AtoB, HmgS, MK, and PMD) were 
weakly correlated with the isopentenol titer (Additional 
file 4C).
To test if higher expression levels of HMGR could 
improve isopentenol production, we built a set of 
strains in which the isopentenol production pathway 
was chromosomally integrated at the idsA locus. The 
∆idsA strains form white colonies instead of the wild-
type yellow color [35] facilitating screening for heter-
ologous pathway integration. The control ∆idsA strain 
harboring a plasmid-borne isopentenol production 
pathway produces ~ 20 mg/L isopentenol (Fig. 5c). The 
∆idsA strain with a chromosomally integrated isopen-
tenol pathway was able to produce isopentenol, but 
less than the control strain with the plasmid-borne 
isopentenol pathway, at titers of ~ 12  mg/L (Fig.  5c). 
However, when HmgR expression was augmented in 
the chromosomally integrated production strain with 
an additional, plasmid-borne copy of HMGR under a 
trc promoter, the isopentenol titer improved 4× over 
the original strain and produced 60 mg/L isopentenol. 
While the cause of lower isopentenol production in the 
∆idsA strains remain unclear, these results provide evi-
dence consistent with the hypothesis where HmgR is a 
Fig. 4 Rational engineering of C. glutamicum host chassis and 
isopentenol production pathway. Analysis of C. glutamicum strains 
∆poxB, ∆ldhA, and double mutant ∆poxB ∆ldhA strains on isopentenol 
production: Strains of the indicated genotype (WT, ∆poxB, ∆ldhA, and 
∆poxB ∆ldhA) were cultivated in 24-well deep well plates. Isopentenol 
titer was measured as described in Additional file 2A, B. Data was 
generated from three independent biological replicates for each 
genotype, and error bars indicate standard error
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rate-limiting step in isopentenol production and pro-
vided a target for further pathway optimization.
Production of isopentenol in C. glutamicum using 
IL‑pretreated sorghum
To test this process with industrially relevant carbon 
sources, we demonstrated that C. glutamicum could 
produce isopentenol from plant biomass hydrolysate. 
We pretreated sorghum biomass using the IL [Ch]
[Lys] to generate a hydrolysate that contained 29.2 g/L 
d-glucose, 16.4  g/L d-xylose, and 5.1  g/L acetic acid 
(Additional file 5A, B). This hydrolysate also contained 
0.01  mM 4-hydroxybenzoic acid and 1.36  mM ben-
zoic acid (Additional file 5A, B). When the production 
strains were grown in the hydrolysate-amended CGXII 
media, no significant growth defect was observed com-
pared to the growth in pure d-glucose supplemented 
CGXII media. Substituting hydrolysate for all added 
water in CGXII media results in a starting concentra-
tion of d-glucose at 1.7% (w/v). Based on our observa-
tions in Fig. 3a, we also prepared two other production 
conditions, where we supplemented pure d-glucose 
such that the concentration was increased to 3.5% or 
4.0% (w/v). In the original hydrolysate-amended con-
dition (with 1.7% d-glucose), we detected trace iso-
pentenol production of ~ 15  mg/L (Fig.  6a). When the 
d-glucose concentration was increased to 3.5% or 4.0%, 
the titer increased to ~ 200 mg/L (Fig. 6a). Any poten-
tial contaminants from IL treated sorghum biomass 
also did not completely inhibit isopentenol production 
at these concentrations. These results demonstrate that 
C. glutamicum has the capacity to function as a micro-
bial chassis for the production of terpenes from renew-
able starting materials.
Ionic liquids do not inhibit isopentenol production
Corynebacterium glutamicum isopentenol production 
strains were tested for isopentenol production with toler-
ated levels of ILs (refer to Fig. 2a–c) higher than the 0.03% 
(w/v) remaining ILs after the ethanol/water washing 
regime [36]. Specifically, IL concentrations ranged from 
75 mM to 600 mM, depending on where a growth defect 
was observed (Fig.  2a–c). After 24  h post-induction, all 
strains except for [Ch][Lys] reached similar high  OD600nm 
measurements; the [Ch][Lys] treated strains grew very 
poorly and did not reach saturation. Isopentenol produc-
tion was measured both 24 and 48 h post-induction.
For  [C2C1im][OAc], 75  mM had no impact on iso-
pentenol production (Fig.  6b, dark blue bars). 250  mM 
 [C2C1im][OAc] delayed isopentenol production, as no 
final product was recovered at 24 h, but the isopentenol 
titer was partially recovered at 48 h timepoint. Samples 
grown in the presence of  [C2C1im][Cl] produced half as 
much isopentenol as the untreated control (Fig. 6b, light 
blue bars). As [Ch][Lys] was inhibitory to C. glutamicum 
growth (Fig.  2b), the strain failed to produce isopente-
nol in its presence (Fig. 6b, lime green bars). [Ch][OAc] 
and [Ch][Cl] had stronger effects on final product titer, 
decreasing isopentenol titer approximately 2–3× com-
pared to the control, with [Ch][OAc] having a larger 
impact on final product titer than [Ch][Lys] (Fig.  6b, 
green bars). The reduction of isopentenol titer of these 
Fig. 5 Analysis of HmgR Protein Abundance vs. Isopentenol Titer. All strains were prepared for isopentenol production in CGXII medium at 
the % (w/v) d-glucose concentration indicated below the graph. a Proteomic analysis of HmgR protein abundance: Absolute abundance for 
HmgR at the timepoints indicated are plotted as a function of cultivation condition. b Correlation analysis between isopentenol titer and HmgR 
protein abundance. Correlation was determined using a linear regression for the Pearson correlation coefficient (PCC) for the two variables. c 
Role of increased HMGR expression on isopentenol titer. All strains were cultivated for isopentenol production in CGXII medium amended with 
4% d-glucose concentration in 24-well deep well plates. White bars: C. glutamicum ∆idsA harboring the plasmid-borne isopentenol production 
pathway. Grey hatched bars: ∆idsA with a chromosomally integrated isopentenol production pathway at the idsA locus. Green bars: ∆idsA with the 
same chromosomally encoded isopentenol production pathway as well as a plasmid-borne HMGR overexpression cassette. For all experiments, 
data was generated from three independent biological replicates for each condition, and error bars indicate standard error
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strains largely correlated with the severity of the growth 
defect, with the exception of [Ch][Cl], which exhibited no 
impact on doubling time but had a measurable impact on 
isopentenol production (refer to Fig. 2b).
In contrast to the cholinium and imidazolium 
based ILs, one of the protic ILs had modest effects on 
the production of isopentenol. Exogenous [DEOA]
[OAc] had a minor impact on isopentenol production 
(Fig. 6b, salmon pink bars), which is reasonably similar 
to [Ch][Cl]. However, strains grown in the presence of 
exogenous ethanolamine ([ETA][OAc]) had a similarly 
reduced titer at the 24  h timepoint, but the isopente-
nol titer was similar to production in the control strain 
when sampled at the 48 h timepoint (Fig. 6b, dark red 
bars). Taken together, these results indicate that C. 
glutamicum is competent to maintain the isopentenol 
titers in the presence of ILs and across several com-
monly used IL formats.
Both strain background engineering and pathway 
engineering improve isopentenol titers
Additional HMGR expression improves isopentenol 
production (Fig. 5c). HmgR from S. cerevisiae is a class 
I HmG-CoA reductase, and preferentially uses NADPH 
as the cofactor rather than NADH [37, 38]. The use of a 
class II HmG-CoA reductase from Silicibacter pomeroyi 
which relies on NADH as a cofactor instead of NADPH 
has been reported previously [39]. We cloned the S. 
pomeroyi hmgr homolog into the isopentenol produc-
tion plasmid and assessed isopentenol production in 
the ∆poxB ∆ldhA background. With the original iso-
pentenol production pathway, C. glutamicum pro-
duces ~ 125 mg/L isopentenol with similar titers at both 
24  h and 48  h timepoints (see Additional file  4A). In 
contrast, ∆poxB ∆ldhA strains showed a delay in initial 
isopentenol production, with lower production after 
24 h (~ 100 mg/L) but an improvement over wild type 
to ~ 500 mg/L after 48 h (refer to Fig. 4).
While titers were comparable at the 24  h timepoint 
with either the S. cerevisiae HMGR or S. pomeroyi hmgr 
genes by the 48  h timepoint, the S. pomeroyi variant 
strains produced close to 1120  mg/L of isopentenol 
(Fig. 7a). At the 72 h timepoint, we detected an increase 
to 1250  mg/L of isopentenol relative to ~ 750  mg/L 
from the unmodified heterologous pathway. This 
improvement in isopentenol production using the path-
way variant suggests that the NADH-dependent allele 
of HmgR was advantageous for isopentenol production 
in C. glutamicum.
Finally, to complete our process characterization, we 
assayed isopentenol production from [Ch][Lys] pre-
treated hydrolysate with the optimized C. glutamicum 
∆poxB ∆ldhA strain harboring the NADH-dependent 
S. pomeroyi hmgr, in the 5 mL cultivation format. The 
starting d-glucose concentration was supplemented to 
4% as determined to be in the range for optimal final 
product titer. At the 48  h timepoint, the isopentenol 
production titer reached ~ 1100 mg/L, equivalent to the 
observed titer from when pure d-glucose was used as 
the carbon source (Fig. 7b). Our  % theoretical yield of 
isopentenol [40] from glucose was 9.7%, and   % theo-
retical yield from sorghum hydrolysate was 8.6%. These 
Fig. 6 Isopentenol Production from [Ch][Lys] Pretreated Sorghum 
Hydrolysates as the Carbon Source. a C. glutamicum was prepared 
for isopentenol production in CGXII media with hydrolysate in 
5 mL culture tubes. Additional d-glucose was supplemented as 
indicated (*). Isopentenol production values are the average of three 
independent biological replicates, and the error bars represent 
standard error. b Isopentenol production in the presence of ILs: CGXII 
minimal media including 4% starting d-glucose was used with or 
without IL. The IL concentrations tested are as listed on the x axis. 
Samples were cultivated in 24-well deep well plates. Data shown are 
after 24 h and 48 h of induction; the isopentenol production values 
are the average of biological triplicates, and the error bars represent 
standard error
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results demonstrate the completion of our microbial 
bioprocess for isopentenol production in the industri-
ally relevant organism C. glutamicum.
Discussion
Different microbial hosts have innate physiological dif-
ferences that make them more or less suitable for a final 
bioconversion process. However, it is unclear a priori 
what parameters dictate final product titer of a given 
heterologous gene pathway. Here we have evaluated the 
advantages of an industrially relevant microorganism, 
C. glutamicum, to express a non-native mevalonate 
pathway consisting of five-genes with the goal of pro-
ducing isopentenol from IL-pretreated plant biomass. 
Our highest isopentenol titers with sugars derived from 
plant biomass are comparable to titers published in E. 
coli which was cultivated in rich media with pure sug-
ars [28, 41]. We also observed that C. glutamicum was 
natively resistant to a wide range of toxic compounds 
associated with the pretreatment process (i.e., ILs) and 
final product (i.e., isopentenol).
Carbon and nitrogen metabolism are closely linked 
through energy-driven processes such as the generation 
of ATP. Thus, the carbon to nitrogen ratio (C:N) is a 
critical parameter and its effect on growth and produc-
tion has been reported in variety of microbial hosts [42, 
43]. This study demonstrates a relationship between 
initial d-glucose concentrations in CGXII media and 
isopentenol production, which corresponds to a C:N 
ratio of 2.8–4.3 where we observed isopentenol pro-
duction. A link between starting d-glucose concentra-
tion and its impact on gene expression (in the context 
of a heterologous gene pathway) has not been described 
before. This compositional profile indicates that com-
mon peptone-based media such as LB (or alternatively, 
defined M9 media) were not optimal for our purposes. 
Our observations are supported by evidence in E. coli, 
where cells exhibit differential transcriptional RNA 
levels and enzyme activities under nitrogen as well as 
carbon limitation [44]. However, it is still unclear how 
the initial cell physiology during exponential phase 
can impact the physiology after d-glucose exhaustion, 
where much of our batch-mode production occurs. A 
previous study also examined the impact of C:N ratio 
on the production of a native molecule [45], but test-
ing a range of C:N values is not yet common practice 
when characterizing new products. The absolute start-
ing d-glucose concentration (or C:N ratio) may be a 
general determinant of final product titer and could be 
beneficial for optimizing other heterologous gene path-
ways in C. glutamicum, such as for the production of 
the anthocyanin food colorant, cyanidin 3-O-glucoside 
[46].
Strain background engineering also played an impor-
tant role in improving isopentenol titer. Having observed 
the undesirable formation of acetate and lactic acid in 
our isopentenol production experiments, we generated 
new strains to redirect metabolic flux away from these 
two organic acids. The single gene deletion strains ∆ldhA 
and ∆poxB did not accumulate their appropriate side-
products, but also did not appreciably increase isopen-
tenol titer. On the other hand, the isopentenol titer was 
Fig. 7 An Engineered C. glutamicum Host Chassis With Modified 
Isopentenol Production Pathway Produces Isopentenol Using 
IL-Pretreated Sorghum Biomass. a Analysis of the engineered 
isopentenol production pathway using a hmgr homolog from S. 
pomeroyi in a 5 mL cultivation format: Isopentenol production was 
performed in a ∆poxB ∆ldhA strain harboring either the original 
isopentenol production pathway or a variant where the S. cerevisiae 
HMGR was replaced with a hmgr homolog from S. pomeroyi. One 
additional timepoint at 72 h post-induction was harvested. b 
Isopentenol production using IL-pretreated sorghum hydrolysate: 
CGXII minimal media was prepared as described previously in 
Fig. 5a. C. glutamicum ∆poxB ∆ldhA was adapted to growth in CGXII 
minimal media containing hydrolysate and assessed for isopentenol 
production at the timepoints indicated. All isopentenol values are the 
average of biological triplicates, and the error bars represent standard 
error
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increased in the double mutant (∆poxB ∆ldhA), which 
was a synergistic improvement over either of the single 
mutants. Genome-scale metabolic flux modeling and 
analysis [47] of these strains could reveal unappreciated 
nuances in host physiology which could inform future 
metabolic engineering work.
Finally, guided by proteomic analysis, pathway engi-
neering resulted in the highest improvements in product 
titers to the grams per liter level. A strong correlation 
between the abundance of HmgR and isopentenol titer 
suggested HmgR as a potential rate-limiting step in this 
pathway. While increasing HmgR protein levels improved 
isopentenol production fourfold, the greatest absolute 
improvement of isopentenol titer was obtained by utiliz-
ing a class II NADH-dependent variant of HmgR from 
S. pomeroyi [39]. We suggest that additional mutagen-
esis of HMGR could lead to broadly applicable improve-
ments for other molecules derived from the mevalonate 
pathway.
The system developed in this study sets the stage 
for characterization of this platform under simulated 
industrial bioreactor conditions, such as the scale down 
approach for 1,5‐diaminopentane [5]. In addition, tech-
noeconomic analyses [48] are needed to fully understand 
the complex variables necessary to implement isopente-
nol production at an industrial scale. Currently, ILs are 
valuable and recycled after generating hydrolysates by 
extensive washing, and thus their concentration in hydro-
lysate is low [36, 49]. However, removal of ILs is not cost-
effective in large-scale industrial applications. As they 
become less expensive, or used in consolidated one-pot 
processes [50, 51], host strains that can tolerate higher IL 
concentrations have the potential for an outsized impact 
on process cost. A higher d-glucose concentration in the 
hydrolysate could simplify the cultivation process we uti-
lized for producing isopentenol from sorghum biomass 
hydrolysate.
Conclusions
This report describes the successful deployment of a het-
erologous mevalonate-based pathway in the Gram-pos-
itive industrial microorganism, C. glutamicum, for the 
production of the biogasoline candidate and commodity 
chemical, isopentenol. Successful production of this final 
product was achieved at greater than 1  g/L from both 
pure glucose as well as IL-pretreated sorghum hydro-
lysate. We highlight the intrinsic capability of C. glutami-
cum as a valuable industrial host through characterizing 
phenotypic responses to emerging IL-based pretreatment 
reagents, and implementing genetic engineering and pro-
cess optimization for terpene production.
Materials and methods
Chemicals and reagents
All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO) or as otherwise indicated, and 
were of molecular biology grade or higher. When cells 
were cultivated in a microtiter dish format, plates were 
sealed with a gas-permeable film (Sigma-Aldrich, St. 
Louis, MO).
Strain and plasmid construction
All strains and plasmids used in this study are listed in 
Additional file 6: Table S1 and their sequences are avail-
able at http://publi c-regis try.jbei.org. Oligo-nucleotide 
primers were synthesized by Integrated DNA Technolo-
gies, Inc. (San Diego, CA). Core primers used to vali-
date genomic deletions are listed in Additional file  7: 
Table S2. Q5 High-Fidelity DNA Polymerase (New Eng-
land Biolabs, Ipswich, MA) was used for polymerase 
chain reaction. Isothermal DNA assembly [52] was uti-
lized to assemble plasmids using 40 nucleotide overhangs 
(NEBuilder HiFi DNA Assembly Master Mix, New Eng-
land Biolabs, Ipswich, MA). Plasmids were constructed 
using chemically competent E. coli DH10β (New England 
Biolabs). Where indicated, the heterologous isopente-
nol production pathway was modified to incorporate 
the hmgr homolog from Silicibacter pomeroyi (NCBI: 
WP_011241944.1) to replace the existing gene from S. 
cerevisiae and the sequence was confirmed by Sanger 
sequencing. Integrated gene cassettes and gene deletions 
were confirmed by colony PCR to verify the complete 
excision at the targeted open reading frame using and 
inspected by agarose gel electrophoresis.
Sorghum biomass pretreatment and regeneration
Whole commercial-grade sorghum plants derived from 
Sorghum bicolor were grown, harvested, and milled in the 
2017 harvest cycle by Chromatin Inc (New Deal, Texas). 
This biomass was pretreated with [Ch][Lys] and after-
wards, enzymatically saccharified for a total time of 72 h 
as described elsewhere [53]. To make CGXII amended 
with hydrolysate, CGXII was prepared using stock solu-
tions of the individual components as described below. 
The hydrolysate was defrosted from storage at − 80  °C, 
filter sterilized through a 0.45-micron filter, and added 
in place of water in CGXII media. Detailed methods for 
the  quantification of sugar and organic acid content is 
included in Additional file 8 (Additional Methods). Crys-
talline d-glucose was added to CGXII media with hydro-
lysate to increase the concentration up to 3.5% or 4% 
(w/v) as indicated.
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Preparation of electrocompetent C. glutamicum cells
Corynebacterium glutamicum was made electrocom-
petent as previously described [54]. In brief, cells were 
grown in NCM medium supplemented with 3% (v/v) 
glycine and electroporated with a Micro Pulser Elec-
troporator (Bio-Rad Laboratories, Inc., Hercules, CA) 
at 10 μF, 600 Ω, and 1800 V. After electroporation cells 
were immediately mixed with 400 μL of BHIS broth and 
heat-shocked for 6 min at 46  °C. After a 2-h outgrowth 
at 30  °C, cells were plated on the appropriate selective 
media.
Growth media composition
Isopentenol production was analyzed in several differ-
ent common growth media. Lysogeny broth (LB): 10 g/L 
tryptone, 5 g/L yeast extract, and 5 g/L NaCl. Tryptone 
and yeast extract were purchased from BD Biosciences 
(Franklin Lakes, NJ). M9 minimal medium (Sambrook 
and Russell, 2001): 2 g/L  (NH4)2PO4, 2 g/L  KH2PO4, 1 g/L 
 K2HPO4, 1  g/L  NH4Cl, 0.5  g/L NaCl, 0.06  g/L  MgSO4, 
1.1  g/L  CaCl2, 20  mg/L thiamine, and 0.2  mg/L biotin. 
CGXII minimal medium [30, 55]: 20  g/L  (NH4)2SO4, 
5  g/L urea, 1  g/L  KH2PO4, 1  g/L  K2HPO4, 0.25  g/L 
 MgSO4·7H2O, 10  mg/L  CaCl2, 10  mg/L  FeSO4·7H2O, 
10  mg/L  MnSO4·H2O, 1  mg/L  ZnSO4·7H2O, 0.2  mg/L 
 CuSO4·5H2O, 0.02  mg/L  NiCl2·6H2O, 0.2  mg/L bio-
tin, 30  mg/L 3,4-dihydroxybenzoic acid, and 21  g/L 
3-morpholinopropanesulfonic acid (MOPS); pH 7.0). 
d-Glucose was used as a carbon source at the % (w/v) 
concentration as indicated.
Toxicity assays
To assess the impact of ILs on the growth of C. glutami-
cum, cells were first adapted to growth in CGXII media 
with 4% (w/v) d-glucose (described below). Then, cells 
were back-diluted into fresh CGXII media at a start-
ing  OD600 of 0.1 supplemented with the following ILs: 
1-ethyl-3-methylimidazolium acetate  ([C2C1im][OAc], 
also referred to as [EMIM][OAc]), 1-ethyl-3-methyl-
imidazolium chloride  ([C2C1im][Cl] also referred to as 
[EMIM][Cl]), cholinium acetate ([Ch][OAc]), cholinium 
chloride ([Ch][Cl]), cholinium lysinate ([Ch][Lys]), etha-
nol amine acetate [ETA][OAc], and diethanol amine ace-
tate [DEOA][OAc] at the concentrations indicated. These 
cultures (100  µL volume per well) were grown at 30  °C 
in 96 well microtiter plates on a Synergy 4 plate reader 
(BioTek Instruments, Winooski VT) and shaken on the 
“high” setting. Optical density was tracked at a wave-
length of 600 nm.
For the isopentenol toxicity assay, single colonies of C. 
glutamicum and E. coli were inoculated in 5 mL LB and 
grown overnight at 30 °C with shaking at 200 rpm. Each 
strain was serially diluted, inoculated on LB agar plates 
containing 2% (w/v) isopentenol. Photomicrographs were 
taken after 2 days of incubation at 30 °C.
Isopentenol consumption or evaporation
Isopentenol evaporation was quantified in a 5  mL cul-
ture tube format and 24-well deep well plate format as 
described in [15]. To measure isopentenol consumption 
by C. glutamicum, wild-type C. glutamicum precultures 
were prepared in LB and back-diluted to an initial  OD600 
of 0.1 into fresh LB spiked with a serial dilution of the 
commercial standard isopentenol. Remaining isopente-
nol was quantified as described in the following section.
Cultivation of C. glutamicum for isopentenol production
All cells taken from − 80  °C glycerol stocks were plated 
on LB agar plates containing the appropriate antibiotic. 
A single colony was inoculated and grown overnight in 
5 mL LB at 30  °C for C. glutamicum on a rotary shaker 
at 200  rpm. Where necessary, kanamycin was added 
to growth media at a final concentration of 50  μg/mL. 
Unless otherwise noted, all seed cultures were first inocu-
lated for growth in culture tubes. If cells were grown in a 
24-well deep well format, 2 mL of culture media was used 
per well. Deep well plates were incubated Infors Multi-
tron Incubator with a 3  mm Orbital Shaking Platform 
shaken at 999  rpm (Bottmingen, Switzerland). When 
grown in a 5  mL culture tube format, 5  mL of culture 
media was used per cultivation. Cultures were shaken at 
200 rpm on a platform shaker. All strains were cultivated 
under aerobic growth conditions.
When grown in rich media, the heterologous isopen-
tenol production pathway was induced when the  OD600 
reached ~ 0.8 with 500  µM IPTG without adaptation. 
When minimal media was used, cells from a seed culture 
were sub-cultured twice to adapt cells to growth in the 
media. In brief, pre-cultured cells in LB were diluted 1:10 
into minimal media and grown overnight at 30  °C with 
shaking at 200  rpm using deep well plates. The adapted 
cultures were then diluted 1:10 into fresh minimal media 
and grown overnight at 30  °C with the same cultivation 
format. After a second back dilution to allow for complete 
adaptation to growth in minimal media, cultures were 
then used for growth assays and production in minimal 
media. The d-glucose concentration was held constant 
throughout all passaging steps required for adaptation. 
Where hydrolysate was used as the carbon source, CGXII 
media was prepared, substituting the volume used for 
 dH2O with the hydrolysate. Crystalline d-glucose was 
added to this solution to increase the starting d-glucose 
concentration. The isopentenol production pathway was 
induced at the same  OD600 as with rich media, and with 
the same concentration of IPTG at 500 µM unless other-
wise indicated.
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To assess isopentenol production under IL stress con-
ditions, the adapted cultures of C. glutamicum were 
first back-diluted to  OD600 of 0.1 into CGXII minimal 
medium including 4% (w/v) d-glucose and the ILs at the 
concentrations described above. The production pathway 
was then induced as before when cultures reached an 
 OD600 of ~ 0.8.
Analytical methods for isopentenol quantification
To quantify isopentenol, 300 μL of cell culture was added 
to 300 μL of ethyl acetate containing n-butanol (10 μg/L) 
as an internal standard and processed as described previ-
ously [28]. Briefly, sample mixtures were shaken at maxi-
mum speed for 15 min using an MT-400 microtube mixer 
(TOMY Seiko, Tokyo, Japan) and then centrifuged at 
14,000g for 3 min to separate the organic phase from the 
aqueous phase. 60 μL of the organic layer was transferred 
into an Agilent glass insert placed inside of a GC vial 
and 1 μL was analyzed by Agilent GCMS equipped with 
a DB-5 column (Agilent Technologies, Santa Clara, CA) 
or Thermo GC-FID equipped with a DB-WAX column 
(Agilent Technologies) for quantification of isopentenol. 
Analytical grade standards were used to calculate analyte 
concentrations and confirm identification of peaks. Sug-
ars and organic acids were quantified exactly as described 
in [56].
Reported isopentenol titers from experiments con-
ducted in the 24-well deep well plate were corrected for 
evaporation at the 48 h timepoint by accounting for the 
amount of product lost from the 24  h timepoint. The 
reported isopentenol titers for the 48 h timepoint are the 
sum of the amount detected by GC analysis plus the esti-
mated isopentenol lost from the 24 h timepoint. Product 
loss from evaporation was estimated using a fitted loga-
rithmic curve from the evaporation rates determined in 
Additional file  1D with different isopentenol starting 
concentrations after 24  h incubation. The formula used 
was y = − 0.129ln(x) + 1.5375 and r2 = 0.9833.
Proteomics
A targeted SRM (selected reaction monitoring) method 
was developed to quantify relative levels of pathway pro-
teins in samples under the various tested conditions in 
a 5  mL cultivation format. At the timepoints indicated, 
1  mL of each sample was pelleted by centrifugation at 
14,000g and flash frozen with liquid nitrogen at − 80  °C 
until ready for processing. Cells were lysed in 100  mM 
 NaHCO3 using 0.1 mm glass beads using a Biospec Bead-
beater (Biospec Products, Bartlesville, OK) with 60  s 
bursts at maximum power and repeated three times. 
Cell lysates were cooled on ice between each round. 
The clarified supernatant was harvested by centrifuga-
tion at 14,000g and the soluble protein concentration 
was determined with the BCA method (ThermoFisher 
Scientific/Pierce Biotechnology, Waltham, MA). The 
SRM-targeted proteomic assays and analyses were per-
formed as described previously [57], on an Agilent 6460 
QQQ mass spectrometer system coupled with an Agilent 
1290 UHPLC system (Agilent Technologies, Santa Clara, 
CA). Equal amount (20  μg) of peptides in each sample 
were loaded and separated on an Ascentis Express Pep-
tide C18 column [2.7-mm particle size, 160-Å pore size, 
5-cm length × 2.1-mm inside diameter (ID), coupled to 
a 5-mm × 2.1-mm ID guard column with the same par-
ticle and pore size, operating at 60  °C; Sigma-Aldrich] 
operating at a flow rate of 0.4 mL/min via the following 
gradient: initial conditions were 98% solvent A (0.1% for-
mic acid), 2% solvent B (99.9% acetonitrile, 0.1% formic 
acid). Solvent B was increased to 35% over 6.5 min, then 
increased to 80% over 1.5 min, and held for 1.5 min at a 
flow rate of 0.6 mL/min, followed by a ramp back down 
to 2% of B over 0.5 min where it was held for 1 min to 
re-equilibrate the column to original conditions. The data 
were acquired using Agilent MassHunter version B.08.02. 
Acquired SRM data were analyzed by Skyline software 
version 3.70 (MacCoss Lab Software). The SRM methods 
and data are available at Panoramaweb [58] (https ://goo.
gl/GgQGn s). Peptide abundances of the same protein 
were summed together to assign the protein abundance 
of a given protein. The average protein value is shown 
from samples in biological triplicate to assess different 
timepoints and growth conditions.
Additional files
Additional file 1. Evaluation of Production Condition and C. glutamicum 
Properties as the Isopentenol Production Chassis. (A‑B) Growth assay of E. 
coli and C. glutamicum to ILs; 0–300 mM  [C2C1im][OAc] and 0–40 mM [Ch]
[Lys] in LB in 96 well microtiter plates. (C) Analysis of isopentenol evapora-
tion or consumption by C. glutamicum in a 5 mL cultivation format. (D) 
The same evaporation assay as in (C), but in a 24 well format.
Additional file 2. Isopentenol Production in C. glutamicum Strains 
Cultivated in Rich vs. Minimal Media. (A) Isopentenol production in 
minimal media: C. glutamicum was prepared for isopentenol production 
in two minimal media; M9 and CGXII supplemented with either 1% or 4% 
d-glucose as the carbon source in 5 mL tubes. (B) Isopentenol production 
in rich media: C. glutamicum was prepared for isopentenol production in 
LB media supplemented with either 1% or 4% d-glucose as the carbon 
source in a 5 mL culture tube. Data shown are production 48 h after 
induction and is the average of biological triplicates; error bars represent 
standard error.
Additional file 3. Impact of Initial Glucose and Nitrogen Concentrations 
On Isopentenol Production in C. glutamicum. (A) Analysis of residual d-glu-
cose in CGXII media with a range of starting d-glucose concentrations 
as indicated in 24-well deep well plates. (B) Analysis of the generated 
succinate titer during isopentenol production in Fig. 3A. (C) Correlation 
of  OD600 of samples grown at different d-glucose concentrations with 
isopentenol titer at the 24 h timepoint. Correlation was determined using 
linear regression for the Pearson correlation coefficient (PCC) for the two 
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variables, and  r2 = 0.00053, and is indicated with a solid black line. (D) 
Impact of different nitrogen concentrations on isopentenol produc-
tion: C. glutamicum was cultivated for isopentenol production in CGXII 
media, where the nitrogen concentration was varied from 20.3 mM to 
1120 mM at the fixed d-glucose concentration of 220 mM. (E) Visualization 
of carbon:nitrogen (C:N) ratio: The C:N ratio ranged from 0.1 to 32.8. For 
simplicity, the potential contribution of carbon from 3,4-dihydroxybenzoic 
acid was excluded from this calculation. When cultivated with 5.5 mM 
d-glucose in CGXII media, C. glutamicum showed poor growth. No other 
gross differences in biomass were noted at other conditions.
Additional file 4. Analysis of Pathway Protein Abundance vs. Isopentenol 
Titer in Three Kinds of Media. (A) Left. Analysis of isopentenol titer meas-
ured in wild-type C. glutamicum. Production of isopentenol from C. glu-
tamicum in CGXII media with d-glucose concentrations as indicated. Right. 
The same strain was cultivated for isopentenol production in LB with 4% 
d-glucose, or M9 media with 4% d-glucose. The production of isopentenol 
from CGXII media with 3% d-glucose is replotted from the left-hand graph 
for ease of comparison. The relevant media and % d-glucose are indicated 
below the graph. Data was generated from three independent biological 
replicates for each condition and the error bars indicate standard error. 
(B) Proteomic analysis of AtoB, HmgS, MK, and PMD protein abundances: 
Each protein abundance is shown at the 24 h and 48 h timepoint in 
wild-type C. glutamicum cultivated with 4% starting d-glucose in LB and 
M9 media, and 2.5–6% starting d-glucose in CGXII media. (C) Correla-
tion between isopentenol titer and each protein abundance at the 24 h 
timepoint. Correlation was determined using linear regression for the 
Pearson correlation coefficient (PCC) for the two variables. Cultivations 
for proteomics samples were performed as described in “Materials and 
methods” section.
Additional file 5. Determination of sugars and aromatics in hydro-
lysate by HPLC. (A) Left Panel. Standards for aromatics (0.5 g/L of each 
compound): A = 4-hydroxybenzoic acid; B = vanillic acid; C = p-coumaric 
acid; D = ferulic acid; E = vanillin; F = benzoic acid. Right Panel. Organic 
acids standards (1 g/L of each compound): G = lactic acid; H = formic 
acid; I = acetic acid. (B) Representative traces for aromatics and organic 
acids from [Ch][Lys] pretreated hydrolysate. Left Panel. Aromatics. Peaks are 
numbered as follows as identified in hydrolysate: 1 = 4-hydroxybenzoic 
acid; 2 = benzoic acid. Right Panel. Sugars and organic acids identified in 
hydrolysate: 3 = d-glucose; 4 = d-xylose; 5 = lactic acid; 6 = acetic acid. 
Concentrations of the sugars and aromatics from the [Ch][Lys] pretreated 
sorghum biomass were as follows. d-Glucose: 29.2 g/L; d-xylose: 16.4 g/L; 
acetic acid: 5.1 g/L; lactic acid: 6.69 g/L; 4-hydroxybenzoic acid: 0.0018 g/L; 
benzoic acid: 0.167 g/L. The analytes for vanillic acid, p-coumaric acid, 
ferulic acid, and vanillin were detected but below the linear range for 
quantification (< 1 mg/L).
Additional file 6. Strains and plasmids used in this study.
Additional file 7. Genotyping primers.
Additional file 8. Additional Methods. Determination of sugars, organic 
acids and monomeric aromatics in the hydrolysate.
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